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152Contemporary management of symptomatic
primary aortic mural thrombus
Himanshu Verma, MBBS, MS, FEVS, Narendranadh Meda, MBBS, MS, Simit Vora, MBBS, MS,
Robbie K. George, MS, DNB, FRCS, and Ramesh K. Tripathi, MD, FRCS, FRACS, Bangalore, India
Objective: Primary aortic mural thrombus (PAMT) is an uncommon condition but an important source of noncardiogenic
emboli with a difﬁcult diagnosis and a high rate of complications, including high mortality. We report our experience of
thromboembolic disease from PAMT and review its contemporary management.
Methods: Retrospective analysis of prospectively collected data of all patients who presented with acute occlusion of a limb
or visceral vessels between January 2011 and September 2013 was performed.
Results: A total of 88 patients presented with acute occlusion of the extremities or visceral arteries. All underwent
extensive evaluation for the possible source of the embolism. Of these 88 patients, 19 patients (mean age, 41.2 years;
male:female ratio, 1:2.1) were found to have aortic mural thrombus as the source of distal embolism. Thrombus was
located in the thoracic aorta in 10 patients, in the perivisceral aorta in three patients, and in the infrarenal aorta in six
patients. Thrombus in the thoracic aorta was treated with stent grafts in four patients, bare metal stents in three pa-
tients, and anticoagulation alone in twopatients. In the suprarenal abdominal aorta, all three patients underwent trapdoor
aortic thrombectomy. Infrarenal aortic thrombus was managed by aortobifemoral embolectomy in two patients, aortic
stenting in two patients, surgical thrombectomy in one patient, and anticoagulation alone in one patient. Successful
treatment, deﬁned as freedom from further embolic events or recurrence of thrombus, was achieved in 14 of 19 patients
(76.4%) with a mean follow-up period of 16.2 months (range, 2-28 months). There were four (21%) thrombus-related
deaths, all due to primary thromboembolic insults. One patient needed a below-knee amputation because of a recur-
rent thrombotic episode.
Conclusions: Symptomatic PAMT is an uncommon but important source of noncardiogenic embolus. It appears to occur
more frequently in young women. Endovascular coverage of the aortic thrombus, when feasible, appears to be an effective
and safe procedure with either stent grafts or closed-cell metal stents. When thrombus is located adjacent to visceral
vessels, it should be managed with an open trapdoor thromboembolectomy. (J Vasc Surg 2014;60:1524-34.)Aortic mural thrombus in the absence of atheroscle-
rotic occlusive or aneurysmal disease is a relatively uncom-
mon entity. Although the cause of aortic thrombus is
idiopathic in many patients, prothrombotic conditions
have been described causing aortic mural thrombus (ie,
malignant neoplasms, thrombocytosis, polycythemia, hy-
percoagulable states, primary tumors of the aorta1-3). Pri-
mary thrombosis of the aorta was ﬁrst described in the late
1940s,4 but the possibility of missing a cardiac embolic
source was always a major issue because of inadequate
imaging techniques at that time.5 With the advent
of two-dimensional transthoracic echocardiography and
transesophageal echocardiography, the sensitivity ofthe Narayana Institute of Vascular Sciences.
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4diagnosis for a cardiac source of embolism has increased
to >95%.6-8
Because most published reports of this entity are
limited to case reports or case series, there is no consensus
on the ideal way of managing this problem. We present our
experience of managing 19 patients with aortic mural
thrombus in an otherwise normal aorta and review pub-
lished literature and contemporary management strategies
of aortic mural thrombus based on morphologic features
of the thrombus as well as its anatomic location.METHODS
As part of our institutional protocol, all patients who
present with acute thrombosis of any arterial bed undergo
thorough evaluation to determine the possible source of
embolism (Fig 1).
We performed a retrospective analysis of hospital re-
cords for all patients who presented with symptomatic
acute thrombosis of the upper limb, the lower limb, or
visceral arterial beds between January 2011 and September
2013. Informed consent was obtained from all patients at
the time of the procedure, and this retrospective study
was approved by the Institutional Review Board. Eighty-
eight patients with acute symptomatic thrombosis of
various arterial beds were identiﬁed. Clinical presentation,
imaging ﬁndings, prothrombotic workup, details of opera-
tive procedures, and follow-up data were reviewed.
Fig 1. Institutional protocol for investigating acute arterial thrombosis. CTA, Computed tomography angiography;
ECG, electrocardiography; MRA, magnetic resonance angiography.
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Fig 2. Classiﬁcation of primary aorticmural thrombus (PAMT).DTA, Descending thoracic aorta; SCA, subclavian artery.
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thrombus attached to the aortic wall in the absence of any
atherosclerotic or aneurysmal disease in the aorta and a car-
diac source of embolus. It could be either sessile or peduncu-
lated (with a free-ﬂoating intraluminal segment).
Because management strategies have largely been depen-
dent on anatomic location as well as on morphologic features
of the thrombus, we classiﬁed PAMT into types I to IV (Fig 2).
All patients underwent follow-up with computed to-
mography (CT) aortography at 6 months. Any residual
or new thrombus at a previous PAMT site as well as any
new embolic event in visceral branches was looked for.
Any new area of thrombus in the aorta or new embolic
event on CT aortography was labeled recurrence.
RESULTS
A total of 88 patients with acute thrombosis of a limb
or visceral vessels were evaluated between January 2011
and September 2013. All patients underwent evaluation
for an embolic source per institutional protocol (Fig 1).Nineteen (21.6%) patients (mean age, 41.2 years; mal-
e:female ratio, 1:2.1) had aortic mural thrombus within an
otherwise normal aorta and a normal heart after thorough
evaluation of the heart (echocardiography) and great ves-
sels on CT or magnetic resonance angiography evaluation
(Fig 1). None of these patients had any signs of either
atherosclerotic change in the entire aorta or any aneurysmal
dilation. Ten patients (52%) had arch and descending
thoracic aortic thrombus; the remaining nine (48%) had
thrombus in the abdominal aorta. Two patients (10.5%)
had thrombus in the arch of the aorta opposite the left sub-
clavian artery origin, eight patients (42%) had thrombus in
the thoracic aorta distal to the left subclavian artery origin,
three patients (15%) had thrombus in the perivisceral
abdominal aorta, and six patients (31%) had thrombus in
the infrarenal aorta.
Interestingly, only one patient (5.3%) was a smoker.
Usual risk factors for atherosclerosis (smoking, hypertension,
diabetes, coronary heart disease, dyslipidemia) were conspic-
uously absent in all patients.
Table I. Clinical presentations, imaging ﬁndings, management, and outcomes of patients with primary aortic mural
thrombus (PAMT) type I and type II
No.
Clinical
presentation (SVS
grade acute limb
ischemia)
Aortic thrombus
CTA/MRA
Distal vessel
embolism
Management of
aortic thrombus
Follow-up,
months
6-month CT/
recurrent embolism/
any complication
Type I PAMT (thrombus in ascending aorta/arch of aorta)
1 Acute limb
ischemia
Between left CCA and
SCA origin, inner
aspect of aorta; sessile
Left brachial
artery
Anticoagulation
alone
10 Thrombus decreased
in size
No recurrence
2 Acute limb
Ischemia
At left SCA origin
extending 1 cm in
distal arch, outer
aspect of aorta; sessile
Left brachial
artery
Anticoagulation
alone
2 Developed severe
psoriasis
Switched to LMWH
Type II PAMT (thrombus in DTA)
1 Acute limb
ischemia (IIa)
DTA, T4-T6; sessile CFA, SFA Covered stent
TAG (W. L. Gore,
Flagstaff, Ariz)
26  100 mm
20 Complete exclusion
No recurrence
2 Acute limb
ischemia (III)
and ischemic
pancreatitis
DTA, T4-T5;
pedunculated
Celiac and SFA Planned for stent
grafting
Expired while awaiting aortic stenting
3 Paraplegia with
bilateral LL
ischemia (III)
DTA, T8-T10;
pedunculated and
infrarenal aorta
Bilateral popliteal Closed-cell bare
metal stenta (24 
70 mm) for DTA,
aortoiliac
embolectomy for
infrarenal aortic
thrombus
Expired in immediate postoperative
period
4 Acute limb
ischemia (III)
DTA, T4-T6;
pedunculated
Rt SFA and
popliteal
Covered stent
Endurant
(Medtronic
Cardiovascular,
Santa Rosa, Calif)
24  80 mm
22 Complete exclusion
No recurrence
5 Acute limb
ischemia (IIb)
DTA, T9-T10;
pedunculated
Rt SFA and
popliteal
Closed-cell bare
metal stent,a
24  70 mm
11 Complete exclusion
No recurrence
6 Acute limb
ischemia (IIa)
and pain in
abdomen
DTA, T6-T8;
pedunculated
Splenic and liver
infarct
Bilateral SFA
Covered stent
Endurant
(Medtronic
Cardiovascular,
Santa Rosa, Calif),
20  80 mm
28 Complete exclusion
No recurrence
7 Pain in abdomen DTA, T8-T11;
pedunculated
Splenic and liver
infarct
Covered stent
Zenith TX2 (Cook
Medical,
Bloomington,
Ind), 22  80 mm
26 Complete exclusion
No recurrence
8 Splenic infarction Abdominal aorta,
T12,L1; sessile
Celiac trunk,
splenic artery
Closed-cell Bare
metal stent,a
22  70 mm
11 Complete exclusion
No recurrence
CCA, Common carotid artery; CFA, common femoral artery; CT, computed tomography; CTA, computed tomography angiography; DTA, descending
thoracic aorta; LMWH, low-molecular-weight heparin; MRA, magnetic resonance angiography; SCA, subclavian artery; SFA, superﬁcial femoral artery; SVS,
Society for Vascular Surgery.
aClosed-cell bare metal stent used: Wallstent (Boston Scientiﬁc, Watertown, Mass).
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tails, characteristics, and management of aortic thrombus
and follow-up details have been grouped for each type of
PAMT in Tables I and II.
All patients diagnosed with hypercoagulable states
were discharged with prescription of lifelong anticoagulation.
Patients without hypercoagulable states and normalﬁndings on follow-up CT aortography were switched to
aspirin 75 mg/day after 6 months.
DISCUSSION
Our series of 19 patients of PAMT is the largest re-
ported so far in the published literature. Our patients
presented with visceral and distal embolization without
Table II. Clinical presentations, imaging ﬁndings, management, and outcomes of patients with primary aortic mural
thrombus (PAMT) type III and type IV
No.
Presentation
(SVS grade acute
limb ischemia)
Aortic thrombus
CTA/MRA
Distal vessel
embolism
Management of
aortic thrombus
Follow-up,
months
6-month CT/recurrent
embolism/any
complication
Type III PAMT (thrombus in visceral segment of abdominal aorta)
1 Paraplegia with
acute renal
failure
Abdominal aorta,
L1-L4
Circumferential with
pedunculated
component
Right renal Trapdoor aortic
thrombectomy
(supraceliac clamp time
25 minutes)
22 Minimal residual sessile
thrombus in CT
No recurrence
Complete recovery from
paraplegia and renal
failure
2 Mesenteric ischemia Abdominal aorta,
T12-L1, sessile
SMA, hepatic and
splenic artery (liver,
gallbladder infarction
with ileal gangrene)
Trapdoor aortic
thrombectomy
(supraceliac clamp time
19 minutes)
Multiple re-look laparotomies
Expired on postoperative day 18
3 Mesenteric ischemia Abdominal aorta,
L1-L3, sessile
SMA with ileal
gangrene, right
renal artery
Trapdoor aortic
thrombectomy
(supraceliac clamp time
22 minutes)
High-output jejunostomy, acute
respiratory distress syndrome, acute
renal failure
Expired on postoperative day 7
Type IV PAMT (thrombus in infrarenal aorta)
1 Acute limb
ischemia (IIb)
Infrarenal, sessile Right popliteal Aortobiiliac embolectomy
for residual thrombus
Closed-cell bare metal
stent,a 18  90 mm
22 No recurrence
2 Acute limb
ischemia R (III)
Infrarenal, sessile Right popliteal Anticoagulation 16 No recurrence
3 Acute limb
ischemia R (II)
Infrarenal at bifurcation,
sessile
Left popliteal Aortic bifurcation
thrombectomy and patch
plasty
21 Recurrent thrombosis in
popliteal segment;
underwent BKA
4 Acute limb
ischemia R (II)
Infrarenal aorta,
pedunculated
Right SFA Aortobiiliac embolectomy 12 No recurrence
5 Acute limb
ischemia (IIb)
Infra renal aorta,
pedunculated
Right SFA Excluder limb (W. L. Gore,
Flagstaff, Ariz), 16 
12  70 mm
15 No recurrence
6 Acute limb ischemia
B/L (IIa)
Aortic bifurcation,
complete occlusion
Aortobiiliac embolectomy 6 Died of malignant disease
BKA, Below-knee amputation; CT, computed tomography; CTA, computed tomography angiography; MRA, magnetic resonance angiography;
SFA, superﬁcial femoral artery; SMA, superior mesenteric artery; SVS, Society for Vascular Surgery.
aClosed-cell bare metal stent used: Wallstent (Boston Scientiﬁc, Watertown, Mass).
Fig 3. Yield of hypercoagulable workup in patients with primary
aortic mural thrombus (PAMT). *One patient had combined
protein C and protein S deﬁciency.
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aneurysm formation and did not demonstrate any athero-
matous or aneurysmal change in the involved aorta. Man-
agement ranged from anticoagulation for sessile, small
thrombus to endovascular stenting or stent grafting for
large or nonvisceral aortic thrombus and open surgical
aortic thrombectomy for visceral thoracoabdominal
thrombus.
Review of published data on aortic mural thrombus un-
til 20141,2,9-15 revealed fewer than 250 cases, the majority
of which were single case reports of mural aortic thrombus.1
In 10,671 consecutive autopsies, Machleder et al reported
an incidence of thoracic aortic mural thrombus at 0.45%
(48 cases), of which 17% (eight cases) had autopsy evidence
of distal embolization.16 Because the disease is mostly
asymptomatic, its true incidence remains unknown. In
our experience, the incidence of aortic thrombus as a
source of embolism has been higher (20%) in comparison
to previously published series (5%).17
Our patients are younger (mean age, 41.2 years)
in comparison to contemporary series (>50 years).1,16
Smoking, hypertension, diabetes, and dyslipidemia18 are
commonly associated comorbidities in previous described
series.1,2 In contrast, only one of 19 patients (5.3%) wasa smoker, and none of the other patients had any other co-
morbidity. Similar to other studies, lower limb ischemia
was the most common presentation, followed by visceral
ischemia. Unlike in our series (60%), yield of hypercoagu-
lable workup has been low in previous reports (25%)1
(Fig 3). Association of various malignant neoplasms has
been previously described,2 and two patients in our study
had malignant disease.
Fig 4. Floating aortic arch thrombus involving supra-aortic vessels (type Ib primary aortic mural thrombus [PAMT])
(a) that was managed by supra-aortic debranching and antegrade endograft implantation (b). (Reproduced from
Rancic Z, Pfammatter T, Lachat M, Frauenfelder T, Veith FJ, Mayer D. Floating aortic arch thrombus involving the
supraaortic trunks: successful treatment with supra-aortic debranching and antegrade endograft implantation. J Vasc
Surg 2009;50:1177-80.  Elsevier 2009.)
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que at mural attachment sites. Therefore, atherosclerosis
as an underlying cause could not be denied, especially in
patients who have risk factors for atherosclerosis.16,18
The morphologic features of the thrombus (sessile vs
pedunculated) and the length of the aortic segment
involved could be predictors of the embolic potential of
such a lesion. Karalis et al reported 73% incidence of
embolic events among patients with pedunculated and
highly mobile aortic thrombi, as opposed to only 12%
when thrombus was layered and immobile.19 A transeso-
phageal echocardiography-based study of protruding aortic
plaques showed that the presence of mobile lesions was
linked to 30 times increased risk of distal embolization.20
In our experience, the source of emboli was from peduncu-
lated and sessile aortic thrombus (nine pedunculated, 10
sessile). In all cases, imaging was obtained soon after the
embolic event happened; it was difﬁcult to interpret
whether original embolizing lesions were sessile, were
pedunculated, or had dislodged, leaving behind the resid-
ual sessile component.
Consistently reported in almost all case series, the distal
arch and the descending thoracic aorta have been the most
common sites of thrombus (74%), followed by the abdom-
inal aorta (14%) and the ascending aorta (12%).1 In our se-
ries, we had two, eight, three, and six patients with type I,
type II, type III, and type IV aortic thrombus, respectively,
and we discuss each group separately.Type I PAMT. This is the least common site for aortic
thrombus and could be manifested with stroke or upper
limb, visceral, or lower limb ischemia.18,21-23 The major-
ity of cases described in the literature are type Ib (varying
degree of involvement of the arch of the aorta) and were
managed in an individualized manner including anti-
coagulation, systemic thrombolysis, and surgical removal of
thrombus under cardiopulmonary bypass through median
sternotomy.18,21-23 For large pedunculated thrombi that
carry a high risk of recurrent embolism, surgical throm-
bectomy with cardiopulmonary bypass should be consid-
ered. Alternatively, successful hybrid supra-aortic
debranching and antegrade stent graft implantation have
also been described (Fig 4).24
Small sessile thrombus possesses a lower risk of embo-
lization and can be managed with anticoagulation and
close follow-up imaging.19,20 In our study, two patients
with type Ib thrombus had small sessile thrombus on the
inner aortic and outer aortic curves in the region of the
left subclavian artery origin. One patient was diagnosed
as lupus anticoagulant antigen positive and managed
with lifelong oral anticoagulation alone, with no recurrent
embolic episodes.
Type II PAMT. Type IIa has been the most common
type of PAMT described in the past.1-5,9-26
The junction of the distal aortic arch and descending
thoracic aorta has been shown to have a predilection for
aortic mural thrombus, although its exact cause is not
Fig 5. Type IIa primary aortic mural thrombus (PAMT). a and b, Preoperative computed tomography (CT) scan
showing pedunculated thrombus distal to left subclavian artery. c, Intraoperative angiogram showing shadow of
thrombus (arrows). d, Six-month follow-up CT scan showing complete exclusion of thrombus.
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aortic isthmus and shear, bending, and torsion stresses26
attributed to aortic trauma during blunt chest injuries
have been described.10,25 Unlike in previous reports, pa-
tients in our series had aortic thrombus not only in the
aortic isthmus but extending into the lower descending
thoracic aorta: type IIb PAMT (Table I).
Although anticoagulation has been the primary
modality of treatment and isolated case reports have shown
resolution of thrombus with anticoagulation alone,2,27
persistence of thrombus load or recurrent embolism risk
has been reported to be high (>25%) compared with
open surgical removal of thrombus (9%).1,25 Recurrent em-
bolism signiﬁcantly increases the risk of major amputation
(9% for anticoagulation alone vs 2.3% for surgical group)
and life-threatening visceral ischemia.1 Another problem
with anticoagulation alone is that neither the duration of
anticoagulation nor the optimal target international
normalized ratio range is known.Minimally invasive options like catheter aspiration
and systemic or catheter-directed thrombolysis, although
described with varying success rates,11,28 carry high risk
of distal embolization during the procedure itself
and do not promise complete removal or exclusion of
thrombus.
Surgical thrombectomy has the advantage of yielding
an aortic wall histopathologic diagnosis, which may be of
diagnostic utility in this relatively unknown entity. However,
surgical options are not complication free, with a reported
mortality of 2.6%29 and perioperative complications ranging
from 28.9% to 71%.15,29 This prompted some investigators
to consider nonoperative management of aortic thrombus
as ﬁrst-line management.15
Endovascular stenting to exclude PAMT has the po-
tential to decrease the size of residual thrombus and recur-
rent embolization in comparison to anticoagulation
alone. It also has fewer perioperative complications in
comparison to open surgical thrombectomy.3,14
Fig 6. Type IIb primary aortic mural thrombus (PAMT). a, Preoperative computed tomography (CT) scan showing
type IIb pedunculated thrombus. b, Six-month follow-up CT scan shows complete exclusion of thrombus by 22- 
70-mm Wallstent (Boston Scientiﬁc, Watertown, Mass).
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has been described as an effective option in contempo-
rary series.1,2,12,13,30
In our experience, eight patients with type II PAMT
presented with either severe limb ischemia or bowel
ischemia, or both (Table I). Given the risks involved with
open surgical thrombectomy, all patients were considered
for stent grafting either during or after addressing of the
acute event (eg, peripheral thromboembolectomy). Being
partially occlusive, visibility of thrombus on aortic angiog-
raphy was anticipated to be poor; hence, landing zones of
stent grafts were planned preoperatively with CT scan, by
use of ﬁxed points (vertebral bodies, origins of left subcla-
vian artery and celiac artery). In addition, obtaining aorto-
grams through a left subclavian artery catheter was useful
and revealed “thrombus shadow” in the majority of cases
(Fig 5). Stent grafts were oversized not more than 5%,
and no balloon molding was attempted. Coverage of
thrombus by at least 2 cm was ensured on both ends to
avoid thrombus from being squeezed out, resulting in
recurrent distal embolization.
In situations in which thrombus shadow is absent,
intravascular ultrasound may be potentially useful in
guiding endografts and assessing post-stenting thrombus
exclusion. Unavailability of intravascular ultrasound in
our center did not allow us to assess its utility.
Although stent grafts were our preferred option,
because of ﬁnancial unaffordability by our patients or un-
availability of appropriate sizes, we placed closed-cell,
bare metal, self-expandable Wallstent (Boston Scientiﬁc,
Watertown, Mass) in three patients with an intention to
plaster the thrombus against the wall to prevent recurrent
distal embolism (Fig 6).
Of eight patients in this group, one patient died of
ischemic pancreatitis in the preoperative period while
awaiting stent graft placement; another patient whounderwent bare metal stenting developed acute renal
failure and respiratory distress and died in the immedi-
ate postoperative period. Of the six surviving patients
who underwent endovascular treatment, the implicated
thrombus was excluded on CT scans at 6 months.
There was no difference in the outcomes between stent
graft and bare metal stent implantation (Fig 5, d and
Fig 6, b).
Therefore, stent grafts and bare metal stents both
appear to be minimally invasive, low risk, and deﬁnitive
therapy for thoracic aortic mural thrombus. The efﬁcacy
of bare metal stents to exclude embolizing carotid plaque
has been well tested,31 and its role in excluding aortic
mural thrombi has been described in the literature with
successful outcomes.14 To be effective for PAMT lesions,
bare metal stents should have low radial force and a
closed-cell design and be available in large diameters of
14 to 34 mm. Although a disease-speciﬁc stent has yet to
be developed for PAMT, Wallstent (Boston Scientiﬁc)
may be the most appropriate currently available stent. It
has a small cell area of 1.08 mm2 and a low radial force
of 0.39 6 0.03 N/cm.32,33 In addition, where long-
segment coverage is required, closed-cell stents have a
theoretical advantage of preserving ﬂow to the arteries sup-
plying the anterior spinal cord and lowering the risk of spi-
nal cord ischemia. In our study, bare metal stents excluded
aortic thrombus adequately with preservation of the
visceral vessel on 6-month follow-up CT scans. The avail-
able maximum diameter (24 mm) of closed-cell bare metal
stents (Wallstent) is a limiting factor for use in the proximal
aorta.
Type III PAMT. Type III PAMT poses a signiﬁcant
challenge because unprotected transfemoral embolectomy
has an increased risk of embolism in visceral vessels.
Balloon embolectomy after temporary occlusion of visceral
vessels has been described as an approach for removal of
Fig 7. Trapdoor thrombectomy for type III primary aortic mural thrombus (PAMT). a and b, Preoperative computed
tomography (CT) scan showing type III PAMT (arrow) in coronal and saggital sections. c,Medial visceral rotation and
supraceliac aortic dissection until diaphragmatic crus (1). Silastic loop control of celiac trunk (2), superior mesenteric
artery (3), and right (4) and left (5) renal arteries. Incision line for trapdoor aortotomy (dotted line) could extend
inferiorly if thrombus extends below in infrarenal aorta. d, Intraluminal thrombus is seen after trapdoor aortotomy
(arrow). Aortic thrombectomy and embolectomy from individual visceral vessel could be performed.
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sidual friable thrombus is high. In our experience, symp-
tomatic type III PAMT involves more than one visceral
artery (celiac, superior mesenteric artery, or renal arteries),
causing signiﬁcant visceral ischemia, and therefore aortic
embolectomy alone will not be sufﬁcient. Acute mesenteric
ischemia, acute renal failure, or acute aortic occlusion
leading to lower limb ischemia mandates urgent explora-
tion and aortic thrombectomy as well as thrombectomy of
individual visceral vessels through a retroperitoneal “trap-
door aortic approach.”34 For infrarenal extension of type
III PAMT, trapdoor incision could be extended farther
inferiorly (Fig 7).
We had three patients of type III PAMT in our series
(Table II). All three underwent trapdoor aortic thrombec-
tomy as an emergency procedure. One patient recovered,
whereas two patients who had extensive gangrenous
changes of viscera died in the postoperative period because
of sepsis. Type III PAMT is devastating as recognition of
this problem is often delayed and the surgical course is
challenging. Delayed presentation of visceral ischemia
may result in multiple organ dysfunction and severe sepsis.
Therefore, despite adequate removal of thrombus, periop-
erative mortality could be high and should be adequately
consented. In our experience, we did not consider fenes-
trated or branched endograft therapies as our patients
were young and long-term effects of endografting are
poorly described. In addition, most cases presented as sur-
gical emergencies, making case planning and graft ordering
very challenging. Also, in the setting of visceral ischemia
and sepsis, use of endografts might have increased risk of
graft infection.
Type IV PAMT. Apart from sessile and pedunculated
eccentric thrombus, complete thrombotic occlusion of the
aortic bifurcation has been described. In the West, acute
thrombotic occlusion of the aortic bifurcation has been
typically attributed to saddle embolus originating from
the heart, but there are many reports in which no cardiac
or proximal embolic source was identiﬁed.1 Similar to
other zones, hypercoagulable states have been identiﬁed as
the cause of PAMT in this zone as well.35-38
We had six patients with infrarenal aortic thrombus
(3 sessile, 2 pedunculated, and 1 with complete occlusion).
All six patients presented with acute lower limb ischemia
(Table II). Of the six patients, thrombus removal was
considered in ﬁve patients, whereas one small sessile
thrombus was managed with anticoagulation alone. Of
the ﬁve, aortobiiliac embolectomy was performed in three
patients. Postoperative CT angiography showed signiﬁcant
residual thrombus in two of these patients, which was
further excluded by bare metal stents. A sessile but embol-
izing thrombus at the aortic bifurcation in another patient
could not be removed by embolectomy and required aortic
thrombectomy and patch angioplasty. Another type IV
PAMT that was within 2 cm of the lower renal artery
was primarily excluded by stent graft.
In the authors’ opinion, unless thrombus is juxtaposed
to the renal artery, aortobiiliac embolectomy with Fogartycatheter is the least invasive and a readily available method
to remove type IV PAMT. However, when thrombus is
juxtaposed to the renal arteries, blind embolectomy may
increase risk of embolization to the renal arteries. There-
fore, in such cases, we consider either open aortic throm-
bectomy or exclusion of thrombus with stent graft. In
addition, embolectomy alone may not be sufﬁcient to
remove adherent aortic thrombus completely.
As residual thrombus can be a potential source of
recurrent emboli, a CT scan should be performed to rule
out any residual thrombus, which should then be excluded
by endovascular stent graft or bare stent.
CONCLUSIONS
PAMT is a signiﬁcant problem in young patients and
has poor outcomes despite aggressive treatment. Advanced
organ ischemia is a poor prognostic sign.
We suggest that all large embolic descending thoracic
and abdominal aortic lesions be covered. Availability of
appropriately sized stent grafts remains a problem in devel-
oping countries. Complete exclusion of type II and type IV
thrombus can be effectively achieved by large-diameter,
closed-cell bare metal stents when stent grafts are not avail-
able or there are concerns with coverage of visceral or spi-
nal cord feeding vessels. In patients with type III thrombus,
we favor trapdoor aortotomy and thromboembolectomy.
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